IP Library Granted Patent US 9,926,612
Granted Patent B2
US 9,926,612 · App. 13/148,289 · Granted Mar 27, 2018

Glycan-specific analytical tools

Inventors: Robert J. Woods (Athens, GA); Loretta Yang (San Diego, CA)
Assignees: University of Georgia Research Foundation, Inc.; Glycosensors and Diagnostics, LLC
C12Y302/01018C12N9/2402C12N9/80C12N9/82C12N15/1089C12Y302/01022C12Y302/01023C12Y302/01113C12Y302/01169C12Y305/01026C12Y305/01052
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,926,612
App. No.
13/148,289
Granted
Mar 27, 2018
Kind
B2
Abstract

Provided are lectenz molecules, which are mutated carbohydrate processing enzymes that are catalytically inactive and that have had their substrate affinity increased by at least 1.2 fold. Further provided are methods for making and methods of using such lectenz. Additional mutated proteins following the lectenz approach are further provided.

Claims (36)

1. A method for generating a lectenz comprising an inactivated mutated carbohydrate-processing enzyme having enhanced affinity for its substrate compared to a corresponding wild-type carbohydrate-processing enzyme, the method comprising:

(a) providing a 3D structure of an enzyme-substrate complex comprising a substrate bound to a catalytically inactive mutant carbohydrate-processing enzyme or a corresponding wild-type carbohydrate-processing enzyme, wherein the catalytically inactive carbohydrate-processing enzyme comprises an amino acid sequence comprising at least one inactivating mutation that eliminates catalytic activity of the enzyme;

(b) performing a computational simulation on the enzyme-substrate complex to predict the per-residue contributions to total interaction energy (ΔE MM ) and/or total binding free energy (ΔG Binding ) for amino acid residues of the enzyme;

(c) analyzing the per-residue energetic contributions to identify at least one amino acid residue as a potential mutation site for enhancing binding affinity of the inactivated enzyme for its substrate as compared to a wild-type enzyme, wherein an amino acid residue is identified as a potential mutation site for enhancing binding activity when

(i) for an amino acid residue located within 5 Å of the substrate in the enzyme-substrate complex, the per-residue contribution of the amino acid residue to at least one of ΔE MM or ΔG Binding is ≥−0.7 kcal/mol; and

(ii) for an amino acid residue located more than 5 Å from the substrate in the enzyme-substrate complex, the per-residue contribution of the amino acid residue to at least one of ΔE MM or ΔG Binding is ≥0.0 kcal/mol;

(d) expressing a library of inactivated mutated carbohydrate-processing enzymes, each inactivated mutated enzyme comprising a plurality of amino acid mutations, wherein

each inactivated mutated enzyme comprises at least one inactivating mutation that eliminates catalytic activity of the enzyme; and

each inactivated mutated enzyme further independently comprises at least one potential affinity-enhancing mutation at a site identified in step (c);

(e) assaying the inactivated mutated enzymes of step (d) for their ability to form the enzyme-substrate complex; and

(f) identifying inactivated mutated enzymes from step (e) that exhibit binding affinities to the substrate that are at least 1.2-fold greater than those of the wild-type carbohydrate-processing enzyme.

2. The method of claim 1 , wherein at least one potential affinity-enhancing mutation is an amino acid substitution that replaces an amino acid residue located within 5 Å of the substrate when bound to the wild-type or inactivated enzyme.

3. The method of claim 2 , wherein at least one amino acid being replaced makes a favorable (<0.0 kcal/mol) per-residue contribution to the total interaction energy (ΔE MM ) or total binding free energy (ΔG Binding ).

4. The method of claim 3 , wherein the per-residue contribution of the amino acid being replaced is between −0.5 kcal/mol and 0.0 kcal/mol.

5. The method of claim 1 , wherein at least one potential affinity-enhancing mutation is an amino acid substitution that replaces an amino acid that makes an unfavorable (>0.0 kcal/mol) per-residue contribution to the total interaction energy (ΔE MM ) or total binding free energy (ΔG Binding ).

6. The method of claim 1 , wherein at least one of step (b) or step (c) comprises computational alanine scanning mutagenesis, direct ΔG calculations, or thermodynamic integration calculations.

7. The method of claim 1 , wherein the simulation comprises molecular dynamics simulation, Monte Carlo simulation, or side-chain rotamer searching.

8. The method of claim 1 , wherein the simulation is performed using classical force fields.

9. The method of claim 1 , wherein the library of step (d) comprises inactivated mutated enzymes comprising the same inactivating mutation.

10. The method of claim 1 , wherein the library of step (d) comprises inactivated mutated enzymes comprising different inactivating mutations.

11. The method of claim 1 , wherein the library is a randomized library.

12. The method of claim 1 , wherein the 3D structure of the enzyme-substrate complex is an X-ray structure.

13. The method of claim 12 , wherein the X-ray structure represents an inactive enzyme-substrate complex, an active enzyme-inhibitor complex, or an enzyme-product complex.

14. The method of claim 1 , further comprising generating the 3D structure using homology or comparative modeling.

15. The method of claim 1 , further comprising generating the 3D structure from crystallographic data from a free enzyme by predicting a co-complex with a substrate using a computational docking program.

16. The method of claim 1 , wherein the carbohydrate-processing enzyme is PNGaseF, and wherein the inactivated mutated carbohydrate-processing enzymes of step (d) comprise amino acid mutations at D57, Y62, E118, S155, 1156, G192 and E206.

17. A method for generating a novel biomolecule, wherein the biomolecule comprises a carbohydrate-binding protein having one or more mutations that:

(i) increase the affinity of the protein to its carbohydrate ligand, as compared to a wild-type protein; and

(ii) have substantially no alteration in the specificity of the protein;

the method comprising:

(a) performing a computational simulation on the carbohydrate-protein complex to predict per-residue contributions to total interaction energy (ΔE MM ) or total binding free energy (ΔG Binding ) for amino acid residues of the protein;

(b) analyzing the per-residue energetic contributions to identify at least one amino acid residue as a potential mutation site for enhancing binding affinity of the protein for the carbohydrate ligand as compared to a wild-type protein, wherein an amino acid residue is identified as a potential mutation site for enhancing binding affinity when the amino acid residue is located within 5 Å of the carbohydrate ligand in the carbohydrate-protein complex, and the per-residue contribution of the amino acid residue to at least one of ΔE MM or ΔG Binding is ≥−0.7 kcal/mol;

(c) expressing a library of mutant carbohydrate-binding proteins, wherein each mutant carbohydrate-binding protein independently comprises at least one potential affinity-enhancing amino acid substitution that replaces an amino acid residue identified in step (b);

(d) assaying the mutant proteins of step (c) for their ability to form the carbohydrate-protein complex and for binding specificity; and

(e) identifying mutant proteins from step (d) that exhibit binding affinities to the carbohydrate that are at least 1.2-fold greater than those of wild-type protein.

18. The method of claim 17 , wherein the biomolecule is a lectin or an antibody.

Assignments (6)
CONFIRMATORY LICENSE Recorded Apr 24, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046003/0329 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 026723 FRAME: 0094. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Feb 13, 2018
From: YANG, LORETTA
To: GLYCOSENSORS AND DIAGNOSTICS, LLC
Reel/Frame 045318/0040 →
CONFIRMATORY LICENSE Recorded Jan 26, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045165/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2015
From: SAMLI, KAUSAR N.
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 034781/0358 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2011
From: WOODS, ROBERT J.
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 026723/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2011
From: YANG, LORETTA
To: GLYCOSENSORS AND DIAGNOSTICS, LLC.
Reel/Frame 026723/0094 →
Continuity (2)
Provisional Application 61193608 · Dec 10, 2008
Related Publication 20120040474A1 · Feb 16, 2012